Aurobindo arm Lannett launches generic of GSK’s drug in U.S.
The launch marks the first product from Aurobindo Pharma’s inhalation pipeline to be commercialised in the U.S.
· 8/31/2026, 2:35:52 PM· 2 min read
The launch marks the first product from Aurobindo Pharma’s inhalation pipeline to be commercialised in the U.S.
Read original story →Related stories
business
Tax cuts for FIIs would be ‘asking govt to fund their under-performance’: Elara Capital MD & CEO
business
Gross GST mop-up grows 15% to ₹2 lakh crore in August
business
Rupee rises 26 paise to 94.96 against U.S. dollar in early trade
business